tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Ownership - Who Owns Annexon Biosciences?

785 Followers

Annexon Biosciences (ANNX) Ownership Overview

18.68%17.86%8.55%54.90%
18.68% Insiders
8.55% Other Institutional Investors
54.90% Public Companies and Individual Investors
The ownership structure of Annexon Biosciences (ANNX) stock is a mix of institutional, retail and individual investors. Approximately 26.41% of the company’s stock is owned by Institutional Investors, 18.68% is owned by Insiders and 54.90% is owned by Public Companies and Individual Investors.
The ownership structure of Annexon Biosciences (ANNX) stock is a mix of institutional, retail and individual investors. Approximately 26.41% of the company’s stock is owned by Institutional Investors, 18.68% is owned by Insiders and 54.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 17, 2024
Ted Yednock
Evp & Chief Innovation Officer
xxxxxxxxxxxxx
$6658
Feb 21, 2024
Jennifer Lew
Evp & Cfo
xxxxxxxxxxxxx
$14339
Feb 21, 2024
Michael Overdorf
Evp & Chief Business Officer
xxxxxxxxxxxxx
$10691
Feb 21, 2024
Ted Yednock
Evp & Chief Innovation Officer
xxxxxxxxxxxxx
$14348

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$97641
Mar 31, 2024
xxxxxxxxxxxxx
$14344366
Mar 31, 2024
xxxxxxxxxxxxx
$18968407

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,386,223Institution4.16%24,694,435
3,361,984Institution3.19%18,927,970
3,297,963Institution3.13%18,567,532
2,877,657Institution2.73%16,201,209
2,814,168Institution2.67%15,843,766
2,645,524Institution2.51%14,894,300
2,000,609Institution1.90%11,263,429
1,867,250Institution1.77%10,512,618
1,830,597Institution1.74%10,306,261
1,315,548Institution1.25%7,406,535

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,297,963Institution3.13%18,567,532
2,877,657Institution2.73%16,201,209
2,814,168Institution2.67%15,843,766
1,867,250Institution1.77%10,512,618
1,830,597Institution1.74%10,306,261
1,315,548Institution1.25%7,406,535
774,638Institution0.73%4,361,212
723,791Institution0.69%4,074,943
696,433Institution0.66%3,920,918
649,218Institution0.62%3,655,097

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,829,766Institution2.68%13,865,853
2,241,544Institution2.13%12,619,893
1,040,148Institution0.99%5,096,725
786,697Institution0.75%4,429,104
313,600Institution0.30%1,536,640
238,574Institution0.23%1,333,629
189,568Institution0.18%1,067,268
130,050Institution0.12%726,980
115,384Institution0.11%649,612
126,812Institution0.12%649,454

FAQ

Who Owns Annexon Biosciences (ANNX)?
According to the latest TipRanks data, approximately 8.55% of the company's stock is held by institutional investors, 18.68% is held by insiders, and 54.90% is held by retail investors.
    What percentage of Annexon Biosciences (ANNX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.55% of Annexon Biosciences (ANNX) stock is held by institutional investors.
      What percentage of Annexon Biosciences (ANNX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.90% of Annexon Biosciences (ANNX) stock is held by retail investors.
        Who owns the most shares of Annexon Biosciences (ANNX)?
        Vanguard owns the most shares of Annexon Biosciences (ANNX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis